Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	197	167	90	75	56	54
Market Cap Growth	68.27%	85.24%	19.92%	34.92%	3.51%	-57.20%
Enterprise Value	219	177	130	103	91	96
Last Close Price	14.70	13.82	9.81	13.80	13.30	28.00
PE Ratio	-	-	1.65	-	-	-
PS Ratio	4.01	4.28	0.87	10.08	-35.00	3.59
PB Ratio	-76.70	6.04	1.51	-1.72	42.04	-8.49
P/FCF Ratio	-	-	1.91	-	-	-
P/OCF Ratio	-	-	1.91	-	-	-
EV/Sales Ratio	4.48	4.53	1.26	13.82	-	6.41
EV/EBITDA Ratio	-	-	2.42	-	-	-
EV/EBIT Ratio	-	-	2.54	-	-	-
EV/FCF Ratio	-5.34	-	2.76	-	-	-
Debt / Equity Ratio	-16.08	1.47	0.36	-1.02	32.36	-11.20
Debt / EBITDA Ratio	-	-	0.40	-	-	-
Debt / FCF Ratio	-	-	0.46	-	-	-
Asset Turnover	0.41	0.30	1.19	0.10	-	0.15
Inventory Turnover	2.65	1.61	3.37	13.40	8.29	2.84
Quick Ratio	0.51	1.19	0.71	0.05	0.71	0.58
Current Ratio	1.02	1.64	0.76	0.06	0.75	0.61
Return on Equity (ROE)	-288.14%	-95.79%	673.95%	-	-	-908.60%
Return on Assets (ROA)	-26.60%	-15.81%	36.89%	-36.95%	-39.55%	-32.56%
Return on Capital (ROIC)	-56.21%	-27.66%	77.76%	-126.97%	-65.17%	-45.42%
Return on Capital Employed (ROCE)	-69.70%	-31.20%	80.10%	-319.80%	-97.50%	-89.00%
Earnings Yield	-33.34%	-25.09%	60.65%	-94.37%	-99.47%	-125.46%
FCF Yield	-20.89%	-21.32%	52.24%	-39.69%	-66.92%	-80.73%
Buyback Yield / Dilution	-9.97%	-4.24%	-79.29%	-78.31%	-156.61%	-21.15%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.